[1] |
CHARNLEY R M. Hereditary pancreatitis[J]. World J Gastroenterol, 2003, 9(1):1-4. DOI: 10.3748/wjg.v9.i1.1.
|
[2] |
RAPHAEL K L, WILLINGHAM F F. Hereditary pancreatitis:current perspectives[J]. Clin Exp Gastroenterol, 2016, 9:197-207. DOI: 10.2147/CEG.S84358.
|
[3] |
PODDAR U, YACHHA S K, MATHIAS A,et al. Genetic predisposition and its impact on natural history of idiopathic acute and acute recurrent pancreatitis in children[J]. Dig Liver Dis, 2015, 47(8):709-714. DOI: 10.1016/j.dld.2015.04.012.
|
[4] |
JOERGENSEN M T, BRUSGAARD K, CRüGER D G,et al. Genetic,epidemiological,and clinical aspects of hereditary pancreatitis:a population-based cohort study in Denmark[J]. Am J Gastroenterol, 2010, 105(8):1876-1883. DOI: 10.1038/ajg.2010.193.
|
[5] |
REBOURS V, BOUTRON-RUAULT M C, SCHNEE M,et al. The natural history of hereditary pancreatitis:a national series[J]. Gut, 2009, 58(1):97-103. DOI: 10.1136/gut.2008.149179.
|
[6] |
|
[7] |
|
[8] |
WHITCOMB D C, GORRY M C, PRESTON R A,et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene[J]. Nat Genet, 1996, 14(2):141-145. DOI: 10.1038/ng1096-141.
|
[9] |
ARDUINO C, SALACONE P, PASINI B,et al. Association of a new cationic trypsinogen gene mutation (V39A) with chronic pancreatitis in an Italian family[J]. Gut, 2005, 54(11):1663-1664. DOI: 10.1136/gut.2004.062992.
|
[10] |
O'BRIEN C M, O'BRIEN A C, GLEESON L,et al. Imaging of genetically-mediated pancreatitis[J]. Clin Imaging, 2020, 65:113-118. DOI: 10.1016/j.clinimag.2020.04.005.
|
[11] |
SHELTON C A, UMAPATHY C, STELLO K,et al. Hereditary pancreatitis in the United States:survival and rates of pancreatic cancer[J]. Am J Gastroenterol, 2018, 113(9):1376. DOI: 10.1038/s41395-018-0194-5.
|
[12] |
HOWES N, LERCH M M, GREENHALF W,et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe[J]. Clin Gastroenterol Hepatol, 2004, 2(3):252-261. DOI: 10.1016/s1542-3565(04)00013-8.
|
[13] |
NéMETH B C, SAHIN-TóTH M. Human cationic trypsinogen (PRSS1) variants and chronic pancreatitis[J]. Am J Physiol Gastrointest Liver Physiol, 2014, 306(6):G466-473. DOI: 10.1152/ajpgi.00419.2013.
|
[14] |
SCHNúR A, BEER S, WITT H,et al. Functional effects of 13 rare PRSS1 variants presumed to cause chronic pancreatitis[J]. Gut, 2014, 63(2):337-343. DOI: 10.1136/gutjnl-2012-304331.
|
[15] |
ENEA A, PIZZOL A, PINON M,et al. Hereditary pancreatitis in Paediatrics:the causative role of p.Leu104Pro mutation of cationic trypsinogen gene also in young subjects[J]. Gut, 2019, 68(4):767-768. DOI: 10.1136/gutjnl-2018-316443.
|
[16] |
SZMOLA R, SAHIN-TóTH M. Uncertainties in the classification of human cationic trypsinogen (PRSS1) variants as hereditary pancreatitis-associated mutations[J]. J Med Genet, 2010, 47(5):348-350. DOI: 10.1136/jmg.2009.072751.
|
[17] |
CHANG Y T, WEI S C, P-C L,et al. Association and differential role of PRSS1 and SPINK1 mutation in early-onset and late-onset idiopathic chronic pancreatitis in Chinese subjects[J]. Gut, 2009, 58(6):885. DOI: 10.1136/gut.2007.129916.
|
[18] |
SZABó A, SAHIN-TóTH M. Increased activation of hereditary pancreatitis-associated human cationic trypsinogen mutants in presence of chymotrypsin C[J]. J Biol Chem, 2012, 287(24):20701-20710. DOI: 10.1074/jbc.M112.360065.
|
[19] |
NEMODA Z, SAHIN-TóTH M. Chymotrypsin C (caldecrin) stimulates autoactivation of human cationic trypsinogen[J]. J Biol Chem, 2006, 281(17):11879-11886. DOI: 10.1074/jbc.M600124200.
|
[20] |
SZMOLA R, SAHIN-TóTH M. Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin:identity with Rinderknecht's enzyme Y[J]. Proc Natl Acad Sci USA, 2007, 104(27):11227-11232. DOI: 10.1073/pnas.0703714104.
|
[21] |
|
[22] |
JONES M R,HALL O M,KAYE A M,et al. Drug-induced acute pancreatitis:a review[J]. Ochsner J,2015,15(1):45-51.
|
[23] |
CEPPA E P, PITT H A, HUNTER J L,et al. Hereditary pancreatitis:endoscopic and surgical management[J]. J Gastrointest Surg, 2013, 17(5):847-857. DOI: 10.1007/s11605-013-2167-8.
|
[24] |
RAMALHO G X, DYTZ M G. Diabetes of the exocrine pancreas related to hereditary pancreatitis,an update[J]. Curr Diab Rep, 2020, 20(6):16. DOI: 10.1007/s11892-020-01299-8.
|
[25] |
|
[26] |
DYTZ M G, MARCELINO P A, DE CASTRO SANTOS O,et al. Clinical aspects of pancreatogenic diabetes secondary to hereditary pancreatitis[J]. Diabetol Metab Syndr, 2017, 9:4. DOI: 10.1186/s13098-017-0203-7.
|
[27] |
WOODMANSEY C, MCGOVERN A P, MCCULLOUGH K A,et al. Incidence,demographics,and clinical characteristics of diabetes of the exocrine pancreas (type 3c):a retrospective cohort study[J]. Diabetes Care, 2017, 40(11):1486-1493. DOI: 10.2337/dc17-0542.
|
[28] |
LANZINGER S, KARGES W, MERGER S,et al. Comparing diabetes due to diseases of the exocrine pancreas to type 1 and type 2 diabetes using propensity score matching[J]. Pancreatology, 2020, 20(5):860-866. DOI: 10.1016/j.pan.2020.05.023.
|
[29] |
DURIE P, BAILLARGEON J D, BOUCHARD S,et al. Diagnosis and management of pancreatic exocrine insufficiency (PEI) in primary care:consensus guidance of a Canadian expert panel[J]. Curr Med Res Opin, 2018, 34(1):25-33. DOI: 10.1080/03007995.2017.1389704.
|
[30] |
LIU Q Y, ABU-EL-HAIJA M, HUSAIN S Z,et al. Risk factors for rapid progression from acute recurrent to chronic pancreatitis in children:report from INSPPIRE[J]. J Pediatr Gastroenterol Nutr, 2019, 69(2):206-211. DOI: 10.1097/MPG.0000000000002405.
|
[31] |
HAO L, BI Y W, ZHANG D,et al. Risk factors and nomogram for common bile duct stricture in chronic pancreatitis:a cohort of 2153 patients[J]. J Clin Gastroenterol, 2019, 53(3):e91-100. DOI: 10.1097/MCG.0000000000000930.
|
[32] |
EWALD N, HARDT P D. Diagnosis and treatment of diabetes mellitus in chronic pancreatitis[J]. World J Gastroenterol, 2013, 19(42):7276-7281. DOI: 10.3748/wjg.v19.i42.7276.
|
[33] |
LIAO K F, LAI S W, LI C I,et al. Diabetes mellitus correlates with increased risk of pancreatic cancer:a population-based cohort study in Taiwan[J]. J Gastroenterol Hepatol, 2012, 27(4):709-713. DOI: 10.1111/j.1440-1746.2011.06938.x.
|
[34] |
ANDERSEN D K, KORC M, PETERSEN G M,et al. Diabetes,pancreatogenic diabetes,and pancreatic cancer[J]. Diabetes, 2017, 66(5):1103-1110. DOI: 10.2337/db16-1477.
|
[35] |
HUANG B Z, PANDOL S J, JEON C Y,et al. New-onset diabetes,longitudinal trends in metabolic markers,and risk of pancreatic cancer in a heterogeneous population[J]. Clin Gastroenterol Hepatol, 2020, 18(8):1812-1821.e7. DOI: 10.1016/j.cgh.2019.11.043.
|
[36] |
LIU Q C, GUO L, ZHANG S,et al. PRSS1 mutation:a possible pathomechanism of pancreatic carcinogenesis and pancreatic cancer[J]. Mol Med, 2019, 25(1):44. DOI: 10.1186/s10020-019-0111-4.
|